Reduction in the number of early melanomas diagnosed during the COVID-19 pandemic: a single-centre cohort study
- PMID: 34260770
- PMCID: PMC8447396
- DOI: 10.1111/jdv.17522
Reduction in the number of early melanomas diagnosed during the COVID-19 pandemic: a single-centre cohort study
Conflict of interest statement
Dr Koch received grants from Novartis and honoraria as speaker and travel fees from Novartis, Bristol Myers Squibb, Roche and Merck & Co. Dr Mondaca has received consulting fees from Roche and Foundation Medicine and honoraria as speaker from Bristol Myers Squibb and Merck & Co.
Figures
References
-
- Breitbart EW, Waldmann A, Nolte S et al. Systematic skin cancer screening in Northern Germany. J Am Acad Dermatol 2012; 66: 201–211. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
